Which hedge funds own MNPR? MONOPAR THERAPEUTICS INC, Q2 2026 13F holders
3 of the hedge funds tracked by WhaleCreep disclosed a position in MNPR (MONOPAR THERAPEUTICS INC) in their Q2 2026 13F filings, worth $69.9m in total. The largest holder by portfolio weight is RA Capital Management at 0.5% of its book.
3tracked managers holding
0opened this quarter
0exited this quarter
Which hedge funds hold MNPR? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 0.5% | $61.8m | 667,207 | 0% | held |
| Millennium Management | Q2 2026 | 0.0% | $4.7m | 50,311 | -5% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $3.4m | 37,004 | -37% | reduced |
How has hedge fund ownership of MNPR changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 3 | $69.9m |
| Q1 2026 | 3 | $42.7m |
| Q4 2025 | 2 | $44.3m |
| Q3 2025 | 1 | $41.8m |
| Q2 2025 | 2 | $22.0m |
| Q1 2025 | 2 | $24.7m |
| Q4 2024 | 2 | $14.9m |
| Q4 2023 | 1 | $16.0k |
Counts every tracked manager that disclosed MNPR in that quarter's filing, including managers that have since stopped filing.